Apotex Inc. v. Sanofi-Synthelabo Canada Inc., [2008] 3 SCR 265

JurisdictionFederal Jurisdiction (Canada)
JudgeBinnie, William Ian Corneil; LeBel, Louis; Deschamps, Marie; Fish, Morris J.; Abella, Rosalie Silberman; Charron, Louise; Rothstein, Marshall
Citation[2008] 3 SCR 265,2008 SCC 61,[2008] ACS no 63,[2008] SCJ No 63 (QL),69 CPR (4th) 251,298 DLR (4th) 385,381 NR 125
Docket Number31881
Subject MatterFOOD AND DRUG CONTROL,PATENTS OF INVENTION
CourtSupreme Court (Canada)
Date06 November 2008
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
179 practice notes
  • Alcon Canada Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2014) 448 F.T.R. 96 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • February 14, 2014
    ...246 F.T.R. 1 ; 31 C.P.R.(4th) 434 ; 2004 FC 88 , refd to. [para. 39]. Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., [2008] 3 S.C.R. 265; 381 N.R. 125 ; 2008 SCC 61 , refd to. [para. 48]. Allergan Inc. et al. v. Canada (Minister of Health) et al. (2011), 400 F.T.R. 164 ; ......
  • AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36
    • Canada
    • Supreme Court (Canada)
    • June 30, 2017
    ...Inc. v. MacMillan Bloedel (Sask.) Ltd., [1981] 1 S.C.R. 504; referred to: Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., 2008 SCC 61, [2008] 3 S.C.R. 265; Eli Lilly and Co. v. Canada, I.C.S.I.D. Case No. UNCT/14/2, March 16, 2017; Apotex Inc. v. Wellcome Foundation Ltd., 2002 SCC 77, [2002] ......
  • Weatherford Canada Ltd. et al. v. Corlac Inc. et al., (2011) 422 N.R. 49 (FCA)
    • Canada
    • Canada (Federal) Federal Court of Appeal (Canada)
    • July 18, 2011
    ...[1989] 2 S.C.R. 574; 101 N.R. 239; 36 O.A.C. 57, refd to. [para. 37]. Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., [2008] 3 S.C.R. 265; 381 N.R. 125; 2008 SCC 61, refd to. [para. 42]. Coco v. Clark (A.N.) (Engineers) Ltd., [1969] R.P.C. 41 (Ch.), refd to. [para. 48]. Beloit C......
  • Merck & Co. et al. v. Apotex Inc. et al., (2010) 381 F.T.R. 162 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • December 22, 2010
    ...F.T.R. 193 ; 67 C.P.R.(4th) 241 ; 2008 FC 825 , refd to. [para. 539]. Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., [2008] 3 S.C.R. 265; 381 N.R. 125 ; 2008 SCC 61 , refd to. [para. Abbott Laboratories et al. v. Canada (Minister of Health) et al. (2008), 337 F.T.R. 17 ; ......
  • Request a trial to view additional results
167 cases
  • Alcon Canada Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2014) 448 F.T.R. 96 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • February 14, 2014
    ...246 F.T.R. 1 ; 31 C.P.R.(4th) 434 ; 2004 FC 88 , refd to. [para. 39]. Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., [2008] 3 S.C.R. 265; 381 N.R. 125 ; 2008 SCC 61 , refd to. [para. 48]. Allergan Inc. et al. v. Canada (Minister of Health) et al. (2011), 400 F.T.R. 164 ; ......
  • AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36
    • Canada
    • Supreme Court (Canada)
    • June 30, 2017
    ...Inc. v. MacMillan Bloedel (Sask.) Ltd., [1981] 1 S.C.R. 504; referred to: Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., 2008 SCC 61, [2008] 3 S.C.R. 265; Eli Lilly and Co. v. Canada, I.C.S.I.D. Case No. UNCT/14/2, March 16, 2017; Apotex Inc. v. Wellcome Foundation Ltd., 2002 SCC 77, [2002] ......
  • Weatherford Canada Ltd. et al. v. Corlac Inc. et al., (2011) 422 N.R. 49 (FCA)
    • Canada
    • Canada (Federal) Federal Court of Appeal (Canada)
    • July 18, 2011
    ...[1989] 2 S.C.R. 574; 101 N.R. 239; 36 O.A.C. 57, refd to. [para. 37]. Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., [2008] 3 S.C.R. 265; 381 N.R. 125; 2008 SCC 61, refd to. [para. 42]. Coco v. Clark (A.N.) (Engineers) Ltd., [1969] R.P.C. 41 (Ch.), refd to. [para. 48]. Beloit C......
  • Merck & Co. et al. v. Apotex Inc. et al., (2010) 381 F.T.R. 162 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • December 22, 2010
    ...F.T.R. 193 ; 67 C.P.R.(4th) 241 ; 2008 FC 825 , refd to. [para. 539]. Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., [2008] 3 S.C.R. 265; 381 N.R. 125 ; 2008 SCC 61 , refd to. [para. Abbott Laboratories et al. v. Canada (Minister of Health) et al. (2008), 337 F.T.R. 17 ; ......
  • Request a trial to view additional results
8 firm's commentaries
  • Species Of Obviousness
    • Canada
    • Mondaq Canada
    • June 8, 2018
    ...Pozzoli SPA v. BDMO SA, [2007] F.S.R. 37 (p. 872), [2007] EWCA Civ 588, at para. 23 2 Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., [2008] 3 S.C.R. 265, 2008 SCC 61 at para. 3 Patent Act, (R.S.C., 1985, c. P-4), s. 28.3. 4 Apotex Inc. et al v. ADIR et al, 2009 FCA 222 (FCA per layden-Steven......
  • Canadian Patent Law Of Obviousness: R.I.P. Fair Expectation Of Success
    • Canada
    • Mondaq Canada
    • March 14, 2016
    ...that the invention was "obvious to try" according to the test in Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61, at para 69, [2008] 3 SCR 265. This dichotomy reflects a tension that has been growing in the law of obviousness ever since the Supreme Court released its leading Sanofi-S......
  • 'Hey AI Bot, Can You Find A Cure?' Artificial Intelligence As 'Persons' In Medicine, Healthcare, And Beyond
    • Canada
    • Mondaq Canada
    • January 27, 2020
    ...point of reference under Canadian patent law remains a "mythical creature": see e.g., Apotex Inc. v. Sanofi Synthelabo Canada Inc., [2008] 3 S.C.R. 265, 2008 SCC 61 The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought a......
  • Extending Recent Promised Utility Doctrine Beyond Pharmaceutical And Chemical Cases
    • Canada
    • Mondaq Canada
    • May 3, 2012
    ...he applied the factors discussed in the Supreme Court of Canada's decision Apotex Inc. v. Sanofi-Synthelabo Canada Inc. (2008 SCC 61, [2008] 3 SCR 265) including whether Eurocopter's patent was 'obvious to On insufficiency, including failing to meet the best mode requirement, Justice Martin......
  • Request a trial to view additional results
4 books & journal articles
  • Patents
    • Canada
    • Irwin Books Intellectual Property Law. Second Edition
    • June 15, 2011
    ...[ MOPOP ]. Patents are granted under statute; no common law right to a patent exists: Apotex Inc. v. Sanof‌i-Synthelabo Canada Inc. , [2008] 3 S.C.R. 265 at [12] [ Sanof‌i ]; Purdue Pharma v. Pharmascience Inc. , 2009 FC 726 at [15] [ Purdue ]. 2 Plant Breeders’ Rights Act , S.C. 1990, c.......
  • Table of Cases
    • Canada
    • Irwin Books Intellectual Property Law. Second Edition
    • June 15, 2011
    ...607 Apotex Inc. v. Sanof‌i-Synthelabo Canada Inc., [2008] 3 S.C.R. 265, 2008 SCC 61 , 69 C.P.R. (4th) 251 ...... 1, 270, 293, 296, 327, 328, 330–32, 335, 336, 343, 420 Apotex Inc. v. Searle Canada Inc., [2000] F.C.J. No. 493, 187 F.T.R. 136 , 6 C.P.R. (4th) 26 (T.D.) .......................
  • Intellectual Property: An Overview
    • Canada
    • Irwin Books Intellectual Property Law. Second Edition
    • June 15, 2011
    ...to prevent copying of inventions or published works of art or literature [ Jefferys ]; Apotex Inc. v. Sanof‌i-Synthelabo Canada Inc. , [2008] 3 S.C.R. 265 at [12], approving Commissioner of Patents v. Farbwerke Hoechst AG , [1964] S.C.R. 49 at 57 (“[t]here is no inherent common law right to......
  • A shift in the Canadian law of obviousness: a comment on Sanofi-Synthelabo Canada Inc. v. Apotex Inc.
    • Canada
    • University of Toronto Faculty of Law Review Vol. 67 No. 2, March 2009
    • March 22, 2009
    ...Editors of the University of Toronto Faculty of Law Review. The author also thanks Alexander Stack and Ariel Katz. (1) 2008 scc 61 , 69 C.P.R. (4th) 251 (2) It is not necessary to consider the two requirements together because the legal tests are independent. This comment focuses on obviou......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT